Global RNA-Targeted Small Molecules Market Size, Status and Forecast 2021-2027

1 Report Overview

• 1.1 Study Scope
• 1.2 Market Analysis by Type
  • 1.2.1 Global RNA-Targeted Small Molecules Market Size Growth Rate by Type: 2016 VS 2021 VS 2027
  • 1.2.2 mRNA Translation Regulation
  • 1.2.3 RNA Splicing Modification
  • 1.2.4 Direct RNA Targeting
  • 1.2.5 Indirect RNA Targeting - Epitranscriptomics
• 1.3 Market by Application
  • 1.3.1 Global RNA-Targeted Small Molecules Market Share by Application: 2016 VS 2021 VS 2027
  • 1.3.2 Hospitals
  • 1.3.3 Laboratories
  • 1.3.4 Phamacy
• 1.4 Study Objectives
• 1.5 Years Considered

2 Global Growth Trends

• 2.1 Global RNA-Targeted Small Molecules Market Perspective (2016-2027)
• 2.2 RNA-Targeted Small Molecules Growth Trends by Regions
  • 2.2.1 RNA-Targeted Small Molecules Market Size by Regions: 2016 VS 2021 VS 2027
  • 2.2.2 RNA-Targeted Small Molecules Historic Market Share by Regions (2016-2021)
  • 2.2.3 RNA-Targeted Small Molecules Forecasted Market Size by Regions (2022-2027)
• 2.3 RNA-Targeted Small Molecules Industry Dynamic
  • 2.3.1 RNA-Targeted Small Molecules Market Trends
  • 2.3.2 RNA-Targeted Small Molecules Market Drivers
  • 2.3.3 RNA-Targeted Small Molecules Market Challenges
  • 2.3.4 RNA-Targeted Small Molecules Market Restraints

3 Competition Landscape by Key Players

• 3.1 Global Top RNA-Targeted Small Molecules Players by Revenue
  • 3.1.1 Global Top RNA-Targeted Small Molecules Players by Revenue (2016-2021)
  • 3.1.2 Global RNA-Targeted Small Molecules Revenue Market Share by Players (2016-2021)
• 3.2 Global RNA-Targeted Small Molecules Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
• 3.3 Players Covered: Ranking by RNA-Targeted Small Molecules Revenue
• 3.4 Global RNA-Targeted Small Molecules Market Concentration Ratio
  • 3.4.1 Global RNA-Targeted Small Molecules Market Concentration Ratio (CR5 and HHI)
  • 3.4.2 Global Top 10 and Top 5 Companies by RNA-Targeted Small Molecules Revenue in 2020
• 3.5 RNA-Targeted Small Molecules Key Players Head office and Area Served
• 3.6 Key Players RNA-Targeted Small Molecules Product Solution and Service
• 3.7 Date of Enter into RNA-Targeted Small Molecules Market
• 3.8 Mergers & Acquisitions, Expansion Plans

4 RNA-Targeted Small Molecules Breakdown Data by Type

• 4.1 Global RNA-Targeted Small Molecules Historic Market Size by Type (2016-2021)
• 4.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Type (2022-2027)

5 RNA-Targeted Small Molecules Breakdown Data by Application

• 5.1 Global RNA-Targeted Small Molecules Historic Market Size by Application (2016-2021)
• 5.2 Global RNA-Targeted Small Molecules Forecasted Market Size by Application (2022-2027)

6 North America

• 6.1 North America RNA-Targeted Small Molecules Market Size (2016-2027)
• 6.2 North America RNA-Targeted Small Molecules Market Size by Type
  • 6.2.1 North America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
  • 6.2.2 North America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
  • 6.2.3 North America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
• 6.3 North America RNA-Targeted Small Molecules Market Size by Application
  • 6.3.1 North America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
  • 6.3.2 North America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
  • 6.3.3 North America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
• 6.4 North America RNA-Targeted Small Molecules Market Size by Country
  • 6.4.1 North America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
  • 6.4.2 North America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
  • 6.4.3 United States
  • 6.4.4 Canada

7 Europe

• 7.1 Europe RNA-Targeted Small Molecules Market Size (2016-2027)
• 7.2 Europe RNA-Targeted Small Molecules Market Size by Type
  • 7.2.1 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2021)
  • 7.2.2 Europe RNA-Targeted Small Molecules Market Size by Type (2022-2027)
  • 7.2.3 Europe RNA-Targeted Small Molecules Market Size by Type (2016-2027)
• 7.3 Europe RNA-Targeted Small Molecules Market Size by Application
  • 7.3.1 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2021)
  • 7.3.2 Europe RNA-Targeted Small Molecules Market Size by Application (2022-2027)
  • 7.3.3 Europe RNA-Targeted Small Molecules Market Size by Application (2016-2027)
• 7.4 Europe RNA-Targeted Small Molecules Market Size by Country
  • 7.4.1 Europe RNA-Targeted Small Molecules Market Size by Country (2016-2021)
  • 7.4.2 Europe RNA-Targeted Small Molecules Market Size by Country (2022-2027)
  • 7.4.3 Germany
  • 7.4.4 France
  • 7.4.5 U.K.
  • 7.4.6 Italy
  • 7.4.7 Russia
  • 7.4.8 Nordic

8 Asia-Pacific

• 8.1 Asia-Pacific RNA-Targeted Small Molecules Market Size (2016-2027)
• 8.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type
  • 8.2.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2021)
  • 8.2.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2022-2027)
  • 8.2.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Type (2016-2027)
• 8.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application
  • 8.3.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2021)
  • 8.3.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2022-2027)
  • 8.3.3 Asia-Pacific RNA-Targeted Small Molecules Market Size by Application (2016-2027)
• 8.4 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region
  • 8.4.1 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2016-2021)
  • 8.4.2 Asia-Pacific RNA-Targeted Small Molecules Market Size by Region (2022-2027)
  • 8.4.3 China
  • 8.4.4 Japan
  • 8.4.5 South Korea
  • 8.4.6 Southeast Asia
  • 8.4.7 India
  • 8.4.8 Australia

9 Latin America

• 9.1 Latin America RNA-Targeted Small Molecules Market Size (2016-2027)
• 9.2 Latin America RNA-Targeted Small Molecules Market Size by Type
  • 9.2.1 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2021)
  • 9.2.2 Latin America RNA-Targeted Small Molecules Market Size by Type (2022-2027)
  • 9.2.3 Latin America RNA-Targeted Small Molecules Market Size by Type (2016-2027)
• 9.3 Latin America RNA-Targeted Small Molecules Market Size by Application
  • 9.3.1 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2021)
  • 9.3.2 Latin America RNA-Targeted Small Molecules Market Size by Application (2022-2027)
  • 9.3.3 Latin America RNA-Targeted Small Molecules Market Size by Application (2016-2027)
• 9.4 Latin America RNA-Targeted Small Molecules Market Size by Country
  • 9.4.1 Latin America RNA-Targeted Small Molecules Market Size by Country (2016-2021)
  • 9.4.2 Latin America RNA-Targeted Small Molecules Market Size by Country (2022-2027)
  • 9.4.3 Mexico
  • 9.4.4 Brazil

10 Middle East & Africa

• 10.1 Middle East & Africa RNA-Targeted Small Molecules Market Size (2016-2027)
• 10.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type
  • 10.2.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2021)
  • 10.2.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2022-2027)
  • 10.2.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Type (2016-2027)
• 10.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application
  • 10.3.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2021)
  • 10.3.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2022-2027)
  • 10.3.3 Middle East & Africa RNA-Targeted Small Molecules Market Size by Application (2016-2027)
• 10.4 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country
  • 10.4.1 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2016-2021)
  • 10.4.2 Middle East & Africa RNA-Targeted Small Molecules Market Size by Country (2022-2027)
  • 10.4.3 Turkey
  • 10.4.4 Saudi Arabia
  • 10.4.5 UAE

11 Key Players Profiles

• 11.1 Accent Therapeutics
  • 11.1.1 Accent Therapeutics Company Details
  • 11.1.2 Accent Therapeutics Business Overview
  • 11.1.3 Accent Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.1.4 Accent Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.1.5 Accent Therapeutics Recent Development
• 11.2 Anima Biotech Inc.
  • 11.2.1 Anima Biotech Inc. Company Details
  • 11.2.2 Anima Biotech Inc. Business Overview
  • 11.2.3 Anima Biotech Inc. RNA-Targeted Small Molecules Introduction
  • 11.2.4 Anima Biotech Inc. Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.2.5 Anima Biotech Inc. Recent Development
• 11.3 Arrakis Pharmaceuticals
  • 11.3.1 Arrakis Pharmaceuticals Company Details
  • 11.3.2 Arrakis Pharmaceuticals Business Overview
  • 11.3.3 Arrakis Pharmaceuticals RNA-Targeted Small Molecules Introduction
  • 11.3.4 Arrakis Pharmaceuticals Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.3.5 Arrakis Pharmaceuticals Recent Development
• 11.4 Epics Therapeutics
  • 11.4.1 Epics Therapeutics Company Details
  • 11.4.2 Epics Therapeutics Business Overview
  • 11.4.3 Epics Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.4.4 Epics Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.4.5 Epics Therapeutics Recent Development
• 11.5 Expansion Therapeutics
  • 11.5.1 Expansion Therapeutics Company Details
  • 11.5.2 Expansion Therapeutics Business Overview
  • 11.5.3 Expansion Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.5.4 Expansion Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.5.5 Expansion Therapeutics Recent Development
• 11.6 Gotham Therapeutics
  • 11.6.1 Gotham Therapeutics Company Details
  • 11.6.2 Gotham Therapeutics Business Overview
  • 11.6.3 Gotham Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.6.4 Gotham Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.6.5 Gotham Therapeutics Recent Development
• 11.7 H3 Biomedicine
  • 11.7.1 H3 Biomedicine Company Details
  • 11.7.2 H3 Biomedicine Business Overview
  • 11.7.3 H3 Biomedicine RNA-Targeted Small Molecules Introduction
  • 11.7.4 H3 Biomedicine Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.7.5 H3 Biomedicine Recent Development
• 11.8 Ribometrix
  • 11.8.1 Ribometrix Company Details
  • 11.8.2 Ribometrix Business Overview
  • 11.8.3 Ribometrix RNA-Targeted Small Molecules Introduction
  • 11.8.4 Ribometrix Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.8.5 Ribometrix Recent Development
• 11.9 Skyhawk Therapeutics
  • 11.9.1 Skyhawk Therapeutics Company Details
  • 11.9.2 Skyhawk Therapeutics Business Overview
  • 11.9.3 Skyhawk Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.9.4 Skyhawk Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.9.5 Skyhawk Therapeutics Recent Development
• 11.10 STORM Therapeutics
  • 11.10.1 STORM Therapeutics Company Details
  • 11.10.2 STORM Therapeutics Business Overview
  • 11.10.3 STORM Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.10.4 STORM Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.10.5 STORM Therapeutics Recent Development
• 11.11 Twentyeight-Seven Therapeutics
  • 11.11.1 Twentyeight-Seven Therapeutics Company Details
  • 11.11.2 Twentyeight-Seven Therapeutics Business Overview
  • 11.11.3 Twentyeight-Seven Therapeutics RNA-Targeted Small Molecules Introduction
  • 11.11.4 Twentyeight-Seven Therapeutics Revenue in RNA-Targeted Small Molecules Business (2016-2021)
  • 11.11.5 Twentyeight-Seven Therapeutics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

• 13.1 Research Methodology
  • 13.1.1 Methodology/Research Approach
  • 13.1.2 Data Source
• 13.2 Disclaimer